ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000252.1|Nonactin_1 # 1 # 141 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.709	BGC0000252.1|Nonactin_1 	1	141	+	Loose	1900	21.9422	mexN	37.84	3003705	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	CTCAGGCGCGCGGTCAACAGCACCATCCTGCGGCGCCTGGTGCGCCCCGAGGAGATCGCCGCCCAGGTCCTGTTCCTGCTCTCCGACCTCTCCGGCGGGATGACCGGACAGGCCGTCAACGTGGACGCGGGGGCTCTGTGA	LRRAVNSTILRRLVRPEEIAAQVLFLLSDLSGGMTGQAVNVDAGAL	MTPRAGISGWCVRHPIATALLTLASLLLGLLAFLRLGVAPLPEADFPTIQINALLPGGSPETMASSVATPLEVQFSAIPGITEMTSSSALGTTTLTLQFSLDKSIDVAAQEVQAAINAAAGRLPVDMPNLPTWRKVNPADSPIMILRVNSEMMPLIELSDYAETILARQLSQVNGVGQIFVVGQQRPAIRIQAQPEKLAAYQLTLADLRQSLQSASVNLAKGALYGEGRVSTLAANDQLFNASDYDDLVVAYRQGAPVFLKDVARIVSAPEDDYVQAWPNGVPGVALVILRQPGANIVDTADAIQAALPRLREMLPATIEVDVLNDRTRTIRSSLHEVELTLLLTIGLVVLVMGLFLRQLSATLIVATVLAVSLSASFAAMYVLGFTLNNLTLVALIIAVGFIVDDAIVVVENIHRHLEAGASKVEAALKGAAEIGFTVISISFSLIAAFIPLLFMGGIVGRLFREFAVSVTVAILISVVASLTLAPMLASRFMPALRHAEAPRKGFAEWLTGGYERGLRWALGHQRLMLVGFAFTVLVAVAGYVGIPKGFFPLQDTAFVIGTSQAAEDISYDDMVAKHRQLAEIIASDPAVQSYNHAVGVTGGSQSLANGRFWIVLKDRGERDVSVGEFIDRLRPQLAKVPGIMLYLRAAQDINLSSGPSRTQYQYALRSSDSTQLALWAQRLTERLKQVPGLMDVSNDLQVGASVTALDIDRVAAARFGLSAEDVSQTLYDAFGQRQVGEYQTEVNQYKVVLELDARQRGRAESLDWFYLRSPLSGEMVPLSAIAKVAAPRSGPLQINHNGMFPAVNLSFNLAAGVSLGEAVQAVQRAQEEIGMPSTIIGVFQGAAQAFQSSLASQPLLILAALIAVYIILGVLYESFVHPLTILSTLPSAGIGAVFLLWAWGQDFSIMALIGIVLLIGIVKKNGILMVDFAIVAQREQGMSAEQAIYQACLTRFRPIMMTTLAALLGAIPLMIGFGTGSELRQPLGIAVVGGLLVSQVLTLFSTPVVYLALERLFHRRGTTTSDGGTAGATAT	4.44	gnl|BL_ORD_ID|2021|hsp_num:0	2217			564	672	chloramphenicol; thiamphenicol
BGC0000252.1|Nonactin_2 # 138 # 1526 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=3-4bp;gc_cont=0.729	BGC0000252.1|Nonactin_2 	138	1526	+	Loose	750	83.9593	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	27.22	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	GTGAGCAAGGAGCACGGCCCGGGGAAGGGCGAACCGCCCCTGCCGGAACAGCTGCTCGCCCCCGCGGCGCGCCCCTGGGCCCCCGGCCCCCGGGACGCGCTGGTCACCGGGATGGGGTTCTGCCTGCCCGGTGCGGGCGACGAGCCGGTGCGCACGGCCGAGCAGGTCTGGGCGGCCGCCTCCACCGGGACCAGTCATGTCGAACGCGACGGCTTCCACCACGGGACCGTACGCGGTGCCCGCGAGGCGTTCGGAGAGCTGCTGCCGGACATACCGGCCCGCTATCTGCGCAGCTACGCCGACGTCCACCTCTACGGGCTGATCTCGCTGGCCGAGGCCTGCCGGGACGCCGGACTCGATTACGGGAAAGGCGAGTTGAGAGGGGCGGACGTGCTGACCGCCCGGGCCGGGGTGGACAGCAACTACGACAGCTACCGCGCCTGGCACGACGCCGATCCGGCGACGGTCACTCCCTCGGACGCCAAGTCCCTCTTCGTACGGCTCCTGGTGGCGGGCACCTCCAGCGACGTCGGCCCCGTCCAGGCCGCGCTGCTCGGTTCCACCGGCGCCAACTACACGGTGAGCTGCGGCTGCGCCTCCTCCTCGGTGCTGCTCGGCATCGCCCGCATGATGATCGCCTCCGGCCAGAGCGACCTGGTCGTGGTCACCGGGGTGGACCGCTTCGACACCGAACGGGTGCTGCACGGACACCGGTTGCGCGAGGTCGTCGAGCGCGAGGGCGTGACGGTGCGGCACAACAGCGATCCGCCGGCAGCACCCCGTCACGACCGGCCGATGCGCCCGTACGACGCGGCGGGCGACTGCATGAACTACGGCGACGGGTCGGTGACCCTGATCCTGGAGAGCCGCGAACACGCCGCCGCGCGGGGCGCCCGGACGCACGGGGCGGTCCTCGGCCAGGCCACCACGCGCGGGGGCCTGAACAGCGCCGTCGCCATCGACACCGGCGGTACGGGGCTGGCCGAAGCGGCCCGCCGCGCCCTGGGCGACCATACCTCGCTGGGGCGGATCCCCTACGTCAACGGGGGCGGCGAGGGCGACGCGCTGTTCACCCGGATCGAGTCCAACGCCGTCCGCGCCCTGTGGGGCGACCGGTCCGAGCAGGTGCTGGTGAGTTCGCAGGAGGCGTGCTTCGGGCACAGCGGCGCGCCGCTCGGCAATCTGGGCACGGCGCTGACGCTGATGATGATGCGCGAGGGAGAGGTCTGCCCCACGGCCAACTGCGCGACCCCGTCGCCCGTCTGCACATTCGACCCGGTCCCCGGCACCAGGACGCGTGCGCTGGGCTTCGACCGGGCCCTGAGCTTCAACTACCAGGTGGGCGGGGTCAACAGCGCACTGCTGCTGGGAGGTGGCGATGTCTGCTGA	MSKEHGPGKGEPPLPEQLLAPAARPWAPGPRDALVTGMGFCLPGAGDEPVRTAEQVWAAASTGTSHVERDGFHHGTVRGAREAFGELLPDIPARYLRSYADVHLYGLISLAEACRDAGLDYGKGELRGADVLTARAGVDSNYDSYRAWHDADPATVTPSDAKSLFVRLLVAGTSSDVGPVQAALLGSTGANYTVSCGCASSSVLLGIARMMIASGQSDLVVVTGVDRFDTERVLHGHRLREVVEREGVTVRHNSDPPAAPRHDRPMRPYDAAGDCMNYGDGSVTLILESREHAAARGARTHGAVLGQATTRGGLNSAVAIDTGGTGLAEAARRALGDHTSLGRIPYVNGGGEGDALFTRIESNAVRALWGDRSEQVLVSSQEACFGHSGAPLGNLGTALTLMMMREGEVCPTANCATPSPVCTFDPVPGTRTRALGFDRALSFNYQVGGVNSALLLGGGDVC	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	111.06	gnl|BL_ORD_ID|1968|hsp_num:0	1943			339	1242	isoniazid
BGC0000252.1|Nonactin_3 # 1516 # 2796 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.731	BGC0000252.1|Nonactin_3 	1516	2796	+	Loose	575	28.8758	KPC-24	27.78	3004496	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; penam	antibiotic inactivation	KPC beta-lactamase	ATGTCTGCTGAGCTGCCTCTGCTGCGGCTTTCCGGCGCCGGGTTCGTCCTGCCGGGGCCGGACGGCCGCGCCTGCACCGACCTGGACACCTTCTGGGGTGTGGTGCGCGACGGGGCGAGCTGCCTCTCCCCGTACGCCCATCCCGAACTCCCCCTCCGTATCGCCGGGACCGTGAACGGCTGGGACCCGGAGACCGAACTCCCGCTGTCGGAACGGCAGATACGCCGTTCCTCGCGCGCCGGGCTGATGGCCACGGGTGCGGTGCACCGGGCGCTGGAGCACGCCGGGCTGAGCGCGGACGACCTCGATCCGGGGCGTACCGCGCTCGTCGCCTGCTCGCTCCAGTTCGCGTTCCCGGAGACCGAGCGCTACTACGCCCTGGCCCGGGACGAGGGGGTCGCCGCCCTCGGCATGGAGTACTGGCTCAACGGGACCCCGCCCAGTGTGGTGGGCACCGTGGCCTCCGGCCTCCGGCTGCCCTGCCAGACGCTGAGCGTGGCGGGCTCCTGCAATGTGGCGCTGCGGACGCTCCACCTCGTCCAGCAGATGTTCCGGTGCGGGGACATCGACCGCGCGATCGTCGTCGGCGTGGACACCACGGTGGACCCGGTCTTCGTGGCAGGCACCAGCCACACCGGACGCAGCGGCTACCGCGCGTCCTCGCTCTCCGACGACCCCGCCGACGTCCGGCCGCACGACGAGATCCAGACCGGCAACGCCACCGGGGAGGGCGCGCTCGCCGTGGTGCTGGAAAACCCGGCGGCGACCGGGGACCGCCCGGGGCTGCTGCACCGCGCGCATCTGCGCACCTCGCGCTCCAACGGCCCCTCCACCGTGGCCACCGGACCGCCCGCCAACGTGGTGGGCGACGTACTGGCCACGCTGGCTTCGGCCCGGCGCGGCCTGGGCGATCTGGCGTTCGTCAACGACTACGCGGACGGCAACCGGTTCGTCGAGGACCACCTGTGCCAGGCGCTCGCCGGGGTGAAGGAGGCGGCCGGGTACGGCGGGGAGCTGCGGCTCACCAACCAGGAGGCGGTCTTCGGGCATGTCGCCGGAACCGGCGGCCTGGTCAAACTCCTCGGCAGCCTCCTCATGCTGCGCCACGGCCATATCGCCCCCAGCGCCAACACCCTGGTCCCGTACGCGGGTCTGCCGGGCGACCCGGTGCTCGCGGGCGGCCTGGCGACCGGCGGAGACAGCGCGCTGGTGCTCGCCTCCGGGGCGGGCGGCGACGCCACGAGCATGGTCATCGAATACGAAGGCGGCGACTTGCCATGA	MSAELPLLRLSGAGFVLPGPDGRACTDLDTFWGVVRDGASCLSPYAHPELPLRIAGTVNGWDPETELPLSERQIRRSSRAGLMATGAVHRALEHAGLSADDLDPGRTALVACSLQFAFPETERYYALARDEGVAALGMEYWLNGTPPSVVGTVASGLRLPCQTLSVAGSCNVALRTLHLVQQMFRCGDIDRAIVVGVDTTVDPVFVAGTSHTGRSGYRASSLSDDPADVRPHDEIQTGNATGEGALAVVLENPAATGDRPGLLHRAHLRTSRSNGPSTVATGPPANVVGDVLATLASARRGLGDLAFVNDYADGNRFVEDHLCQALAGVKEAAGYGGELRLTNQEAVFGHVAGTGGLVKLLGSLLMLRHGHIAPSANTLVPYAGLPGDPVLAGGLATGGDSALVLASGAGGDATSMVIEYEGGDLP	MSLYRPLVLLSCLSWPLAGFSATALTNLVAEPFAKLEQDFGGSIGVYAMDTGSGATVSYRAEERFPLCSSFKGFLAAAVLARSQQQAGLLDTPIRYGKNALVPWSPISEKYLTTGMTVAELSAAAVQYSDNAAANLLLKELGGPAGLTAFMRSIGDTTFRLDRWELELNSAIPGDARDTSSPRAVTESLQKLTLGSALAAPQRQQFVDWLKGNTTGNHRIRAAVPADWAVGDKTGTCGVYGTANDYAVVWPTGRAPIVLAVYTRAPNKDDKHSEAVIAAAARLALEGLGVNGQ	145.39	gnl|BL_ORD_ID|2643|hsp_num:0	3024			0	333	
BGC0000252.1|Nonactin_4 # 2793 # 4394 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.776	BGC0000252.1|Nonactin_4 	2793	4394	+	Loose	500	48.521	Mycobacterium tuberculosis inhA mutations conferring resistance to isoniazid	24.82	3003393	protein variant model	S94A	n/a	isoniazid-like antibiotic	antibiotic target alteration	isoniazid resistant inhA	ATGACCCACGTTCACAGCACGGCGACGCGGCCCGGGACGGCCGCGGGAGGGGACCCGTCGCGGGCGCCGGTCAGCACCCGCGTGGTCGTCGACGCCGCCGGGGGCGACGGTCCTGCCGCCGGGGCCCTCTCCGACGCGCTCACCGCGCTCGGCCTCGCCCCCGAGGCCCCGGACACCGAGGCCCCGGACACCGGCCGCGCCGATTCCGGCGACCCCGCCCCGGCCGCCTACTGCGCTCTGCTGCTCGGCGAGGAGGCGTACGGCGCCGGACGCTCGGCGGGCCTGGACCGCTCACGCGTCCGGGCCGCCGCGCTGGCGATTGCGGCGGCGGGCCGGGGACGGCTCGTCCTGGTGACCGACGCGACGGGCGAGACCCACGCCGGAACCGACCCCGACCGGTACGCGCGGCTCGCCGCCGACCGGGCCTGGTGGCAGCACCTGGTCACCGAGGTGGCCGGGCGCGGCGTCACCGGCAACACCGTGGTCACGGGCTACTCCCCCGGCCTGGGCCACCGGCTGTCCGCCGAGGCCGAGGCCGGGCTGCTGCGCTGTCTCGTGCAGCGCCGGCCCACCACGGCCGCCGATGTCGCGGCCACCGTCGCCTTCCTGGTCTCCGAGGGGTGTTCGTACCTGGTCGGCGAGACTCTGCCGGTCGACGGGGGCGCGGGCCTCGGCCAGATCCCGTCCCTGCCCGCCGGCCCGCCGACGACGGCCCCCGCACCGCGCCGCGGTGCTCCGCGGGAGCAGCCGCCGCCGGAGCCGGTGAGCGGTCAGGACCTCCTGGGCCACAAGGTCCTGGTGGCGGGCGCGAGCAGCGGCATCGGCCGGGCCGCGGCCCTGCACCTGGCCGGACGCGGGGCCGACGTGATCCTGGCCGCCCGCCGGACGCAGGCGCTGGAGGAGGTGGCCGCCGAGATCGAGGCCCGGGGCCGGCAGGCCTGGACCCTGCGCTGCGACCTCTCCGACGCCGAGGACGCCGCTTCTCTGGGCGAACGGGCCTGGAAGGCGGCCGACGGCGTCACCGCCCTGCTGTACGCGGCGGGGCACCTGGGCTTCAGCGCGGTCGGCGGCGACCCCGCTTCCGCCGCCCGGACCTTCGCGGTGAACCTGCACAGCTTCGTCGCCGTCACCGAGTACCTGGCGGCCCGCTGGCGGGACGAGAGGATGCCCGGAGCGGTGGTCGGGGTCTCCTCGGTCAGCTCCACGCTCAGCCCGGTGGCGGGCCTGGAGTACTACGGGGCGAGCAAGGCCGCGATGGCGCAGTACATCCGCTGTCTCGCGGTCTCGGTGGGCCGCCACGGCATCCGCGCCAACTGCGTGGCTCCCGGCATCATCGAGACGCCGATGGGCGACGCGGCGGGGCCCGACCACCGGCGCGGCTGGATCAGCCGGATACCGGCCGGGCGGGTCGGCGACCCGCACGAGGTGGCGGCGGTCCTCGGCTATCTGCTGAGCGGTTCGGCCTCCCGGGTGACCGGTGCCGTGCTGCGCGCGGACGGCGGCTTCGGCCTCGGTGACGTGGCTCCGCTGCGGCCGGGATACCCGGAGCGGGCCTTCCCTGCACCGGCGCTCCCGGAGCGGGCGGAGGGGGAGAACCGATGA	MTHVHSTATRPGTAAGGDPSRAPVSTRVVVDAAGGDGPAAGALSDALTALGLAPEAPDTEAPDTGRADSGDPAPAAYCALLLGEEAYGAGRSAGLDRSRVRAAALAIAAAGRGRLVLVTDATGETHAGTDPDRYARLAADRAWWQHLVTEVAGRGVTGNTVVTGYSPGLGHRLSAEAEAGLLRCLVQRRPTTAADVAATVAFLVSEGCSYLVGETLPVDGGAGLGQIPSLPAGPPTTAPAPRRGAPREQPPPEPVSGQDLLGHKVLVAGASSGIGRAAALHLAGRGADVILAARRTQALEEVAAEIEARGRQAWTLRCDLSDAEDAASLGERAWKAADGVTALLYAAGHLGFSAVGGDPASAARTFAVNLHSFVAVTEYLAARWRDERMPGAVVGVSSVSSTLSPVAGLEYYGASKAAMAQYIRCLAVSVGRHGIRANCVAPGIIETPMGDAAGPDHRRGWISRIPAGRVGDPHEVAAVLGYLLSGSASRVTGAVLRADGGFGLGDVAPLRPGYPERAFPAPALPERAEGENR	MTGLLDGKRILVSGIITDSSIAFHIARVAQEQGAQLVLTGFDRLRLIQRITDRLPAKAPLLELDVQNEEHLASLAGRVTEAIGAGNKLDGVVHSIGFMPQTGMGINPFFDAPYADVSKGIHISAYSYASMAKALLPIMNPGGSIVGMDFDPSRAMPAYNWMTVAKSALESVNRFVAREAGKYGVRSNLVAAGPIRTLAMSAIVGGALGEEAGAQIQLLEEGWDQRAPIGWNMKDATPVAKTVCALLSDWLPATTGDIIYADGGAHTQLL	198.14	gnl|BL_ORD_ID|1964|hsp_num:0	1574			12	789	isoniazid
BGC0000252.1|Nonactin_5 # 4391 # 5206 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.768	BGC0000252.1|Nonactin_5 	4391	5206	+	Loose	700	26.9498	vanS gene in vanL cluster	28.12	3002938	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	ATGACCGCCACCGCGCAAGCAGGCCGCCACCCGGTCGCCCTCGTCGCCGGCGCCTCCTCCGGGATCGGGGCCGCCGTCGCCCGCCGACTGGCCGCGCGCGGCAGCGCCGTGGCGCTGGTCGGGCGGCGGGAGCCCGAGCTGAAGGAGGTCGCGGAGTCGATCCGCGCGGCCGGCGGAACCGCGCTGTCGCTCGCCCTGGACCTGGCCGGGCCGGGTGCCCCCGCCGAGGCGGTCGCCGCCACCGCGGCCGGACTGGGGCCGGTCGGGCTGCTGGTGTGCAGCGCGGGCGCCATCCGGCTGGCCGCCGTCCACGAGACCGAGGAGCGGCACTGGGAACGGCAGTTGCGGGTGAACCTCACGGTGCCGTTCCTGCTGGCCCGTGAGGTGCTGCCCGGCATGCGGGAGCGCGGCTTCGGCTGGGTCGTGAACATCGGCTCCGGTGTGGGCTCGGAGGTGGTGCCGGGCAGCGGCGGCTACGGCGTCAGCAAGCACACCGTGCACCGGCTCACCGAGCTGATCCACGAGGAGAACCGCGACCTCGGGATCCGCGCGGTCACCGTCGCCCCGGGCTGGGTCTCCACCCGGCTCGCGGCCCGGCCCGCCGATCTCGGGGTGCCCGAGGAGGAGGTGCTGGACGCGGAGGACATCGCGGACACCGTCGCGTGGCTGCTGGACCGTCCGGCCCGGATGAGCGTCGGCCCGCTGGTCCGCGTCGAGCCCTCGGCGAGCCGGGCCGCCGCCGGTGACGCCATGACCCGCCATCTGACCCGTTCCCGCGCCGAGGGCGCCGGACCGGATGCTGAGGAGACCCGCTGA	MTATAQAGRHPVALVAGASSGIGAAVARRLAARGSAVALVGRREPELKEVAESIRAAGGTALSLALDLAGPGAPAEAVAATAAGLGPVGLLVCSAGAIRLAAVHETEERHWERQLRVNLTVPFLLAREVLPGMRERGFGWVVNIGSGVGSEVVPGSGGYGVSKHTVHRLTELIHEENRDLGIRAVTVAPGWVSTRLAARPADLGVPEEEVLDAEDIADTVAWLLDRPARMSVGPLVRVEPSASRAAAGDAMTRHLTRSRAEGAGPDAEETR	MKSKAETTTIKQILIKYLVTIGLSMLAYLVFLLTILIIMRNFVWDGTEPIYRVLHFFYRLFNFEGILIIGVILILFVVTLFFVMKIIGYLKQIIEATKQLLEKPEQRVKLSSGLFELQEEMNQLREKNNADNRAAKEAEKRKNDLIVYLAHDLRTPLTSVIGYLTLLKEEPEISVQTRAKYTNIALSKAFRLEELLSEFFDVTRFNLTNLTINEELVDLSVMLEQISYEFLPILEEKKLSWNLHVESNIKSLLDPGKMERVFDNLMRNAINYSFEDTIIDLSLEKKESQAIFKITNRTYTIPKEKLEKIFEPFYRMDTSRSSSTGGTGLGLPIVREIIEASKGTINVSSSNNEMTFIIYLPYID	74.45	gnl|BL_ORD_ID|4734|hsp_num:0	744			675	771	vancomycin
BGC0000252.1|Nonactin_6 # 5206 # 6915 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.744	BGC0000252.1|Nonactin_6 	5206	6915	+	Loose	2300	29.6462	evgS	26.25	3000833	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam; tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGCAGGACCACCCTCATCGAGCACGACGTGCCGGTGGAGATGCGCGACGGGACGGTGCTGCGGGCCGATGTGTGGCGCCCCGCCGAAGGACCGGCCTCGCCCGCCGTGCTCTTCCGCACCCCGTACGGCAAGTCCCCGCTGGGTCTTGCCACCCTGACCCCGGCCCAGTGCGTGGACCGGGGGTACGCGGCGGTCGTGCAGGACACCCGGGGCCGGTTCGGCTCGGAGGGCGAGTGGGCGCCGCTGGACTGGTCCCAGGAGGGGCCCGACGGGTACGACACCGTCGAGTGGACCGCCGAACAGCCTTGGTGCGACGGGAACGTGGCCATGGCGGGCACCTCGTACCAGGCGATCGTCCAGTGGCTGGCCGCCATGGAGAAGCCGCCGCACCTGCGGGCCATCGCGCCCACGATGTCCACCTCGGCCCCCTTCGACGCCGAGCAGCTCGGCGGTTTCCTGCGGCTGGACCACCTCACGAGCTGGCTCGGCCTGACCGCGCTGGAGTGGGTGCAGCGCCGGGCGGCGGCGGGCGATCCGGTGGACGGGGCGGTCGTCGCCGAGGTCGTGCAGCTGCTCACCGCACCCGAAGTGCCGCTGCGCCGCTGGCCGTTGTCGACCATCCTCGACTTCGAGGGGTTTCCCGGCCGGCTGCGGGACATCTTCGCGGGGCACGTGGCGACGGTGGCCGACTACCACCTCGGGGAAGTCGGGGTGCCCACCTTCTCGGTCGGCGGCTGGTACGACGTGTTCTCCCACGGCACGATCGAGCTGCACCGCGCCGTGCGCGCCCTGGACCCGGTGGCGGGACGGCACGAGCTGGTCGTCGGACCCTGGGTGCACTCGGGTCAACTGCCGCAGGTGCAGGGCGAGGTGAACACGGGGCCCTACGGTTCGGCGCAGGGCGCACGGCTGGCCGATCTGCACCTGGACTTCTTCGACCGCCATCTACGGCCGGCCGGGGGGACGACGGGCCGGGACTCCGGCGGGGACGTGCGGTATTTCCTCTTCGGCGATGACGCCTGGCACCGGGCCGCGAGCTGGCCGCCGCCCGAGGCCGTCGACGCGCCCTGGTACCTGGCGGGTCCGGCCGACGGCGAGGAGGGCGGCAGGCTGCTGCCCGCCCCGCCCCGGGAGGCCCCGGGCCACGACGCGTTCACCTACGACCCGGAGGACCCGGTGCCCTCGCACGGCGGGCGGGTGCTCCAGCTCGGCAGGCTGGCGGCGGGCCCGCTCAACCAGGCGCATCTGGAGGACAGGCCGGACGTGCTCTGCTACACCTCCGAGCCGCTCACCGAGCCGCTGGACGCCGTCGGCCGGCAGCGGCTGCGGCTCCGCTTCGGCTCGGACGCACCCGCCACCGCCGTGGTCGCCAAACTCACCGACGTACACCCGGACGGGCGTTCGCTGCTCGTGGCCGAGGCCAGCCTCCGGCTGGAGGCCGAGGGGGACGGCCCGCGGGACGAGCCGTACGACGCCGATCTGCTGCTCGGGGACACCGCGTGGCGCTTCGCCCCCGGGCACCGGCTGCGGGTCCACGTCACCAGCAGCAACTTCCCCCATCTGGACCGGCACCCCAACATCCCGGGCCCGGTCGGCGAGGCGGAGCACTGCCGCACCGCCCGCCAGTCGGTCTGGTACGGCGGCCCGTACGAGAGCGTGCTGCGGCTGAGCACCCTGCCCGCGCCGAGCGCCGGGGAGACCGCGTGA	MGRTTLIEHDVPVEMRDGTVLRADVWRPAEGPASPAVLFRTPYGKSPLGLATLTPAQCVDRGYAAVVQDTRGRFGSEGEWAPLDWSQEGPDGYDTVEWTAEQPWCDGNVAMAGTSYQAIVQWLAAMEKPPHLRAIAPTMSTSAPFDAEQLGGFLRLDHLTSWLGLTALEWVQRRAAAGDPVDGAVVAEVVQLLTAPEVPLRRWPLSTILDFEGFPGRLRDIFAGHVATVADYHLGEVGVPTFSVGGWYDVFSHGTIELHRAVRALDPVAGRHELVVGPWVHSGQLPQVQGEVNTGPYGSAQGARLADLHLDFFDRHLRPAGGTTGRDSGGDVRYFLFGDDAWHRAASWPPPEAVDAPWYLAGPADGEEGGRLLPAPPREAPGHDAFTYDPEDPVPSHGGRVLQLGRLAAGPLNQAHLEDRPDVLCYTSEPLTEPLDAVGRQRLRLRFGSDAPATAVVAKLTDVHPDGRSLLVAEASLRLEAEGDGPRDEPYDADLLLGDTAWRFAPGHRLRVHVTSSNFPHLDRHPNIPGPVGEAEHCRTARQSVWYGGPYESVLRLSTLPAPSAGETA	MKFLPYIFLLCCGLWSTISFADEDYIEYRGISSNNRVTLDPLRLSNKELRWLASKKNLVIAVHKSQTATLLHTDSQQRVRGINADYLNLLKRALNIKLTLREYADHQKAMDALAEGEVDIVLSHLVTSPPLNNDIAATKPLIITFPALVTTLHDSMRPLTSPKPVNIARVANYPPDEVIHQSFPKATIISFTNLYQALASVSAGHNDYFIGSNIITSSMISRYFTHSLNVVKYYNSPRQYNFFLTRKESVILNEVLNRFVDALTNEVRYEVSQNWLDTGNLAFLNKPLELTEHEKQWIKQHPNLKVLENPYSPPYSMTDENGSVRGVMGDILNIITLQTGLNFSPITVSHNIHAGTQLSPGGWDIIPGAIYSEDRENNVLFAEAFITTPYVFVMQKAPDSEQTLKKGMKVAIPYYYELHSQLKEMYPEVEWIQVDNASAAFHKVKEGELDALVATQLNSRYMIDHYYPNELYHFLIPGVPNASLSFAFPRGEPELKDIINKALNAIPPSEVLRLTEKWIKMPNVTIDTWDLYSEQFYIVTTLSVLLVGSSLLWGFYLLRSVRRRKVIQGDLENQISFRKALSDSLPNPTYVVNWQGNVISHNSAFEHYFTADYYKNAMLPLENSDSPFKDVFSNAHEVTAETKENRTIYTQVFEIDNGIEKRCINHWHTLCNLPASDNAVYICGWQDITETRDLINALEVEKNKAIKATVAKSQFLATMSHEIRTPISSIMGFLELLSGSGLSKEQRVEAISLAYATGQSLLGLIGEILDVDKIESGNYQLQPQWVDIPTLVQNTCHSFGAIAASKSIALSCSSTFPEHYLVKIDPQAFKQVLSNLLSNALKFTTEGAVKITTSLGHIDDNHAVIKMTIMDSGSGLSQEEQQQLFKRYSQTSAGRQQTGSGLGLMICKELIKNMQGDLSLESHPGIGTTFTITIPVEISQQVATVEAKAEQPITLPEKLSILIADDHPTNRLLLKRQLNLLGYDVDEATDGVQALHKVSMQHYDLLITDVNMPNMDGFELTRKLREQNSSLPIWGLTANAQANEREKGLSCGMNLCLFKPLTLDVLKTHLSQLHQVAHIAPQYRHLDIEALKNNTANDLQLMQEILMTFQHETHKDLPAAFQALEAGDNRTFHQCIHRIHGAANILNLQKLINISHQLEITPVSDDSKPEILQLLNSVKEHIAELDQEIAVFCQKND	47.54	gnl|BL_ORD_ID|1214|hsp_num:0	1318			528	753	erythromycin; cloxacillin; tetracycline; oxacillin; norfloxacin
BGC0000252.1|Nonactin_7 # 6912 # 8579 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.737	BGC0000252.1|Nonactin_7 	6912	8579	+	Loose	1000	37.7354	almE	20.67	3007433	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	polymyxin resistance operon; alm glycyltransferase	GTGATCGACGATGTGCTCGATCCGGCGTCCGCCGCCGTGCCCACGGCGGAGCAGTGCGTGCTGGGTCCCCTGCTCAGGCGACGTGCCGCCGCAGCACCGGCGGCGCCGTACGCGTTGATGCCGGACGGTGACCTCTGGACGTACGCGCGCACCCTCCGGGAGACCGAGGAGACGGCCGCCGCGCTCCAGGCGCTGGGAGTCGTCCCGGGCGAACTGGTGCTGAGCTGGCTGCCCAACGGACCCGACGCGCTGCGCGCCTGGTACGGGGTCAACCTGGCGGGCGCGGTCCTGGTGCCGCTCAACATCGCCTACCGGGGTGCGATCCTGCGTCAGGTGATCGCCGACAGCGGGGCCGAGGTGCTGATCTGCCGGCCGTCGCTGGCGGCCCGGCTGGAGGATTCGGACGACGCGGTGGGGGCGGTGCGCACGGTGGTCCTGCTGCCGGGGCCCGAGGACGCGGCCCAGGACGTGGAGGCGCTCGCCGGGCGGCTGGCCACGCGCTTCCGGGTGGAGACCGCACTGCGCGCGGACCGGGCGGAGTTCGCGGAGCCGGTGCCCGCCCCCCGGCCGTGGGACCCGCAGACCGTCATCTACACCTCCGGGACGACCGGTCCGTCCAAGGGCGTCGTCTCCTCCTACGCGCACCTGTACAGCAGTTGCACCGCCGCGTTCCACGGCATGGCCGGACCGGAGGACCGCTATCTGCTGCAACTGCCGCTGTTCCACGCGGGCGGCACGATCGGCGCGTACGGGATGCTGGTGCACGGCGGTTCGGTGACGGTCGTGCCCGCGTTCACCACCGGGGAGTTCTGGCCGCTGATCCGGCGGACGGGGACGACCCTGTGCACGCTGCTCGGCGTGATGGCGACCTATCTGCTCAAGCAGCCGCCGCTGCCGCAGGACACCGCGCACCCGTTGCGGGCGGCCTACGTCATCCCGTTCACCGAGGGGGCGACGGAGTTCTCCAAGCGGTTCGGGGTCCCGGTCCGCGCGCTGTTCAACATGACCGAGGTGTCGTGTCCGGTGCTCTCCGCGCCGGACCACCACCCGGGCGTCCCGATGCACTGCGGGGAGCCCCGGCCGGGGATCGCCGCGCGGGTCGTCGACGACCACGACCGGGAGGTGGCGGACGGCGAGGCGGGCGAACTGGTGCTGCGCGCGGACCGTCCGTGGTCGTTCCTGAGCGGCTACCTCGGCCGGCCCGCCGAGACGGCCGCCGTCTGGCGCAACGGCTGGTTCCACACCGGGGACACCTTCCGCCGGGCCCCGGACGGCGGGCTGGTCTTCGTGGACCGCAAGAAGGACGCCATCCGCAGGCGCGGCGAGAACATCTCCTCCTTCGAGGTGGAGGCGCAGGCGGTGGCCCACCCGGGGGTGCTGGAGGCGGCGGCGGTGGCGGTGCCCGGCGACGAGGGCGAGGACGAGGTGCTGCTGGTGGTGGCGGACCGCGACCCCTCGGCCCCGGTCGACCCGGCGGCGCTGCTGGAGTTCCTGCGGGAGCGGCTGGCCCACTTCATGCTGCCGCGCTACATCCGGGTGCTGCCCGAGCTCCCGAAGACTCCCACCGGCAAGCCGACCAAGCACACGCTGCGCGCCGAGGGCGTGGTGGCGGGGACGTGGGACCGCGAGGCCGCGGGCATCCGGATACGCAGGGAGAAGATCGTATGA	MIDDVLDPASAAVPTAEQCVLGPLLRRRAAAAPAAPYALMPDGDLWTYARTLRETEETAAALQALGVVPGELVLSWLPNGPDALRAWYGVNLAGAVLVPLNIAYRGAILRQVIADSGAEVLICRPSLAARLEDSDDAVGAVRTVVLLPGPEDAAQDVEALAGRLATRFRVETALRADRAEFAEPVPAPRPWDPQTVIYTSGTTGPSKGVVSSYAHLYSSCTAAFHGMAGPEDRYLLQLPLFHAGGTIGAYGMLVHGGSVTVVPAFTTGEFWPLIRRTGTTLCTLLGVMATYLLKQPPLPQDTAHPLRAAYVIPFTEGATEFSKRFGVPVRALFNMTEVSCPVLSAPDHHPGVPMHCGEPRPGIAARVVDDHDREVADGEAGELVLRADRPWSFLSGYLGRPAETAAVWRNGWFHTGDTFRRAPDGGLVFVDRKKDAIRRRGENISSFEVEAQAVAHPGVLEAAAVAVPGDEGEDEVLLVVADRDPSAPVDPAALLEFLRERLAHFMLPRYIRVLPELPKTPTGKPTKHTLRAEGVVAGTWDREAAGIRIRREKIV	MPYNSATDLLQREGYGVVHNQFINKMAMCCETRHSILAAIQANRHAPALWVKQKTYTYQEMTDMALSLSDYWHLQGVQRVAILSVRDLAAYSAIWASYLGGMTYIPLNARATTEQIQETLIATQCDSIMVDAQQLSRLSSLLDTCIDRLHIYALPDVDMEPLRQQYPQHTFHTVQITEQDVELLVAKYHLDNEHEYAYIMQTSGSTGKPKRIAVSYSNLHCYISQIDKLFPLNAQDRVGQYSDLTFDLSVHDIFYSLISGACLYVVPELAKLSPAEFIRHHQLTVWLSVPTVIELALQRQTLTPHSLPSLRLSFFCGQALLHDLAEQWQQATQQPVINLYGPTECTIAITYHRFVAHSGMASVPIGRAFEEECLAIINEQGELMRFESAPEGYRGELLLSGKQLVNGYLNDPLNTQSAFFQHEGRIWYRSGDIVTKSNGVLIHLGRRDHQVKIAGQRVELEEIETVVRRVTQAHSVAIVPWPLSESGYASGTVAFVDTHTQWQPDLWLSQCKQQLNPTFVPKRWYAIEQLPRNANGKTDIKALQQQLASQTYETSH	99.82	gnl|BL_ORD_ID|4935|hsp_num:0	5928			594	1638	colistin A; colistin B
BGC0000252.1|Nonactin_8 # 8576 # 9469 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.735	BGC0000252.1|Nonactin_8 	8576	9469	+	Loose	300	28.8758	dfrA26	48.0	3002857	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGAACCAGGAAGCATTCCGGGCGGGCCAGGAACCCCCGGCCGAGTGGGCGGGGGCGGCGACCGAGTCGTTCGCGGACTTCGCCGACCGGGTGGACGGCAAGGAGGTCGTACCGCTGCGGGCCTCGCTTGCGGGCGGGGTCGCCACCCTGACGCTGGACCGGCCGCACCGCCGCAACAGCCTCGACCTGACGCTCTCCCGCCATCTGCTGCTCGGCCTGATGTGCGCGGGCGACGACCCCCGGGTGCGTACGGTCGTGATCACCGGGAACGGCGGGGCGTTCTGCGCGGGCGACGACGTCGGGAGCGTACGGCGGTGGCGGCTGGGCGACCGGGCGGACACCCCCTTCGACCCGATCACCTCGGACGCCCACTACCTGCGGGTCTGCGAGGCGATCCTGCATCTGCCGAAGCCGGTGGTCGTGGGGCTGACCGGGGCGGCGGCGGGCGCCGGGGCGGAGATCGCCTGCGCCGCCGACTTCCGGCTGGCGGACACCCGTGCCTCGATCGGCAGTTGCCTGGCCGGGGTCGGGCATGTGGGGAACGTGGTCCTGATGTCCCGGCTGACCGGTCCGGCGCGGGCGACGGAGATCTACCTCACCGGGCGGATGGTCTCCGGGGACGAGGCGGTGCGCCTGGGGCTGTTCGACCGGCTCTGCGAACCGGAGGATTTCGACCGCGAACTGGCCGATCTGGCGGGCCGGTTCGCGGCACTGCCGACCGCTTCGGTGGGGCTGTTCAAGGAGTTGCGGGAGCGGAGCTGGGGGCAGCCGGCCGAGTACGGGCTGCGGCTCCAGGACACGTACCACCTGAAGACGCACGCGACGGTGGCCGACGCCCGGGAGGGGATGGCCGCGTTCACGGAGAAGCGGCCGCCCCGCTTCACCGGCGCCTGA	MNQEAFRAGQEPPAEWAGAATESFADFADRVDGKEVVPLRASLAGGVATLTLDRPHRRNSLDLTLSRHLLLGLMCAGDDPRVRTVVITGNGGAFCAGDDVGSVRRWRLGDRADTPFDPITSDAHYLRVCEAILHLPKPVVVGLTGAAAGAGAEIACAADFRLADTRASIGSCLAGVGHVGNVVLMSRLTGPARATEIYLTGRMVSGDEAVRLGLFDRLCEPEDFDRELADLAGRFAALPTASVGLFKELRERSWGQPAEYGLRLQDTYHLKTHATVADAREGMAAFTEKRPPRFTGA	MADEEYDPLLDDDMEDAKVAVIAARAQNGCIGRHGKLPWKLPGDLKYFRERTWGKPIIMGRKTWESLNGALPGRTNIVVTRQQGYEAEGARVVDSIEEAISLAQSIALIEAVDEIMVLGGGEIYTQALPQADILYLTEVHASVDGDAFFPDVDLSQYQETQRQDFEPSGGNPYPFSFVVYQRT	162.30	gnl|BL_ORD_ID|598|hsp_num:0	654			93	168	trimethoprim
BGC0000252.1|Nonactin_12 # 12393 # 13088 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.741	BGC0000252.1|Nonactin_12 	12393	13088	+	Loose	575	25.0238	PLA-6	39.53	3006971	protein homolog model	n/a	n/a	carbapenem; cephalosporin	antibiotic inactivation	PLA beta-lactamase	ATGGCAAAGATCCTTTTCGTGGTGTCCGGCGCGGACCACTGGACCCTGGCGGACGGCACGGCCCACCCCACGGGCTTCTGGGCCGAGGAGGCCGTGGCGCCGTACCGGGCGTTCACCGACGCCGGGCACGAGGTGGTCGTCGCCACCCCGGGCGGCGTCGTCCCGACCGTGGACCGGGGCAGCCTGGCGCCCGACGTCAACGGCGGGCAGGAGGGCGCCGACGCGGTGGCGGCCGGTCTTGAGGCGTTCGAGGAGCTGCGGCGGCCGGTCGCCCTGGAGGACGTGGACCCGGACGTGTACGACGCCGTCTTCTACCCCGGCGGCCACGGCCCGATGGAGGACCTCGCGGTGGACCCCGTCTCCGGGCGGCTGCTCGCCCGGGTGCTGGCTTCGGGCAAGCCGCTCGGCGTGGTCTGCCACGGCCCGGCGGCGCTGCTGGCCGCGACCGGACCCGACGGCCGGTCCGCGTTCGCCGGGTATCGGCTGACGGGCTTCACCAACGCCGAGGAGGCCCAGGCGGGCTTCGCGGACAAGGCGAAGTGGCTGCTCCAGGACCGGCTGGTGGCGCTGGGCGCGGACTTCCAGGAAGGTGAGCCCTGGGCGCCGTTCGTCATCACCGACCGGAACCTGATCACGGGTCAGAACCCGGCCTCCTCCGTCCCGTTGGCCGCCGAACTGCTCAACCGGCTCGGCTGA	MAKILFVVSGADHWTLADGTAHPTGFWAEEAVAPYRAFTDAGHEVVVATPGGVVPTVDRGSLAPDVNGGQEGADAVAAGLEAFEELRRPVALEDVDPDVYDAVFYPGGHGPMEDLAVDPVSGRLLARVLASGKPLGVVCHGPAALLAATGPDGRSAFAGYRLTGFTNAEEAQAGFADKAKWLLQDRLVALGADFQEGEPWAPFVITDRNLITGQNPASSVPLAAELLNRLG	MRQYRFALLPLLAALALPGWAHQATVTTVKQAESQLQGRVGYAELDLASGQLLAGYRSDERFPMMSTFKVLLCGAVLSRVDAGEEQLDRRIHYRQQDLVEYSPVTEKHLTDGLTVGELCAAAITLSDNTAANLLLTTLGGPQGLTSFLRHSGDQTSRLDRWETELNEARPGDVRDTTTPQAMARTLRNLLTGSVLSSASQQQLQRWMVEDKVAGPLLRSVLPAGWFIADKTGAGNRGSRGIIAALGPDGKAARIVVIYLTGTPATMDERNKQIAAIGATLIRHWSADENRP	79.38	gnl|BL_ORD_ID|4558|hsp_num:0	5628			627	756	
BGC0000252.1|Nonactin_13 # 13129 # 13512 # -1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.724	BGC0000252.1|Nonactin_13 	13129	13512	-	Loose	750	25.0238	cmlA9	46.15	3005043	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGTCCCAGACAGCAATGGGCACCGTCCAGAAGGCGCACGAGGAGTGCGGCCTCTCCTACAATCGCTGCCGCTGGTGCGGCACCGCCTCGTTCCGGCGGCTGCTGTGCCCGGTGTGCGCGTCGAGCGAACTGGAGCCCGAACGCACCACCGGCCACGGCGTGGTCGTCCGGACCGCCGTGGTCCACCGCTATACCGAGGCTGCGCGCAACGAGTCCCTGGTGCGGTTCTCGGAAGGGTTCGTCTTCCGCTGCCAGATCGTGGGGGCGGCTCCGCACCTGGTGACGGTCGGTGCGCGCGTCCGGCCCGTCTCCGGGGACGAGCCCGAGACGGGCGCGGTGGTGCTGGAGCTCTGCGAGCCGCCCGCGCGGCGGGACTGGGTCTGA	MSQTAMGTVQKAHEECGLSYNRCRWCGTASFRRLLCPVCASSELEPERTTGHGVVVRTAVVHRYTEAARNESLVRFSEGFVFRCQIVGAAPHLVTVGARVRPVSGDEPETGAVVLELCEPPARRDWV	MTTTRPAWAYTLPAALLLMAPFDILASLAMDIYLPVVPAMPGVLNTTPSIIQLTLSLYMVMLGVGQVIFGPLSDRVGRRPILLVGATAFVAASLGAACSSTALAFVAFRLVQAVGASAMLVATFATVRDVYANRPEGAVIYGLFSSMLAFVPALGPIAGALIGEFWGWQAIFITLAALASLALLNASFRWHETRPLDQARTQRSVLPIFASPAFWVYTVGFSAGMGTFFVFFSTAPRVLIGQAGYSEIGFSLAFATVALVMVTTTRFAKSFVAKWGIAGCVARGMALLVSGAILLGIGQLFGSPSFFSFILPMWVVAVGIVFTVSVTANGALAQFDDIAGSAVAFYFCIQSLIVSIVGTLAVTLLNGDTAWPVICYATAMAVLVSLGLALLRSRDAATEKSPVV	31.44	gnl|BL_ORD_ID|2773|hsp_num:0	3786			321	435	chloramphenicol
BGC0000252.1|Nonactin_14 # 13623 # 14315 # -1 # ID=1_14;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.714	BGC0000252.1|Nonactin_14 	13623	14315	-	Loose	375	41.2022	nalD	25.12	3000819	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGGGAGGTGCTCGCACAGGCGGCCTTCCGGCTCTTCCTGGAGCGGGGCTTCGAGCGGACGACCGTGGACGACATCGTGGCGCTGGCCGGGGTGGGCCGGCGTTCGTTCTTCCGCTACTTCCCGTCCAAGGAGGACGCGGTCTTCCCGGACCACGAGCGCTGCCTCGCCGAGACGACCGAGTTCCTGGCCGCCGTCGACGACAGCGACCCGGTCGGCGCGGTGTGCGACGCCGCGCGCATCGTGCTGCGGATGTACGCGGCCAACCCCGAGTTCTCCGTGCAGCGCTACCGCCTCACTCGGGAGGTGCCGGGGCTGCGGACGTACGAACTGTCGGTGGTGCGCCGTTACGAACAGACTCTCGCCGGACATCTGCGGGGTCGCTTCGGCGAGGGTCGCGACGGGGAGCTGCGGGCCGAGGTGATCGCCGCTTCGGTGGTCGCCGCGCACAACAACGGGCTTCGGCTGTGGCTGCGTTCGGGCGGGGCGGGCGACCCCGAGGCGGCTGTGGATCATGCGCTCGCCCTGGTCCGAGAGGTGTGGGGGCGGCCTGCCGTCCCCACACCGGCCACCCCCTTTCCGGTCTCCGGTGGCGGCGACGGGAAAGGGGAGGTGATCGTGATGGTCGCGCGGAAGGGCACCCCGATGTGGCGTGTCGTGCAGCAGATCGAGGCAGCCGTCGGCGAGAACTGA	MREVLAQAAFRLFLERGFERTTVDDIVALAGVGRRSFFRYFPSKEDAVFPDHERCLAETTEFLAAVDDSDPVGAVCDAARIVLRMYAANPEFSVQRYRLTREVPGLRTYELSVVRRYEQTLAGHLRGRFGEGRDGELRAEVIAASVVAAHNNGLRLWLRSGGAGDPEAAVDHALALVREVWGRPAVPTPATPFPVSGGGDGKGEVIVMVARKGTPMWRVVQQIEAAVGEN	MRRTKEDSEKTRTAILLAAEELFLEKGVSHTSLEQIARAAGVTRGAVYWHFQNKAHLFNEMLNQVRLPPEQLTERLSGCDGSDPLRSLYDLCLEAVQSLLTQEKKRRILTILMQRCEFTEELREAQERNNAFVQMFIELCEQLFARDECRVRLHPGMTPRIASRALHALILGLFNDWLRDPRLFDPDTDAEHLLEPMFRGLVRDWGQASSAP	108.49	gnl|BL_ORD_ID|2335|hsp_num:0	1213			33	627	erythromycin; ciprofloxacin; tetracycline; ceftazidime; ceftriaxone; meropenem; novobiocin; azithromycin; trimethoprim; sulfamethoxazole; chloramphenicol; aztreonam; colistin A; colistin B; ampicillin; nalidixic acid; panipenem; ticarcillin; trimethoprim-sulfamethoxazole
BGC0000252.1|Nonactin_15 # 14485 # 15270 # 1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.665	BGC0000252.1|Nonactin_15 	14485	15270	+	Loose	500	30.4166	GOB-34	28.0	3005683	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	GOB beta-lactamase	GTGAGCTTGAGGATCGTTGTCTGTGTGAAGTACGTGCCCGACGCGACCGGTGACCGGCGTTTCGCCGATGACCTGACGCTGGACCGTGAGGATGTCGACGGTCTGTTGTCGGAGCTGGACGAGTACGCGGTCGAGCAGGCGTTGCAGATCGCTGACGGGGCGGACGATGCGGAGATCACCGTGGTGACGGTGGGTCCGGAGGATGCCAAGGACGCGTTGCGCAAGGCGTTGTCGATGGGTGCGGACAAGGCGGTTCACGTCGAGGACGACGATCTGCACGGCAGTGATGTGATGGGGACGTCGCTGGTGCTGGCGAAGGCTGTGGAGAAGGCCGGGTATGACCTGGTGATCTGTGGGATGGCGTCGACGGACGGTGTGATGGGTGTGCTGCCGGCGTTGCTGGCGGAGCGTCTGGGTGTGCCGCAGGTGACGTTGCTGTCCGAGGTCGCGGTGGACGGTGGTGTGGTGACGGGGCGGCGTGACGGTGACACGGCGTCCGAGCAGCTTGAGGCGTCGCTTCCCGCGGTGGTGTCGGTGACCGACCAGTCGGGTGAGGCCCGTTACCCGTCGTTCAAGGGGATCATGGCGGCGAAGAAGAAGCCGGTGGAGTCGCTGGACCTGGACGATCTGGGTCTGGACGCGGACGAGGTCGGTCTGGCGGGTGCGTGGACGGTGGTGGATTCCGCCACCGAGCGTCCGGCGCGGACGGCGGGCACGATCGTGAAGGACGAGGGTGAGGGCGGCAGGCAGCTCGCCGGGTTCCTCGCGGGCCAGAAGTTCATCTAG	MSLRIVVCVKYVPDATGDRRFADDLTLDREDVDGLLSELDEYAVEQALQIADGADDAEITVVTVGPEDAKDALRKALSMGADKAVHVEDDDLHGSDVMGTSLVLAKAVEKAGYDLVICGMASTDGVMGVLPALLAERLGVPQVTLLSEVAVDGGVVTGRRDGDTASEQLEASLPAVVSVTDQSGEARYPSFKGIMAAKKKPVESLDLDDLGLDADEVGLAGAWTVVDSATERPARTAGTIVKDEGEGGRQLAGFLAGQKFI	MKRITTLLFLLVCFGWNAQVVKEPENTPKEWSQNYEPFRIAGNLYYVGTYDLASYLIVTDKGNILINTGLTGSLSTIKENIAKLGFNYKDIKILLLTQAHYDHTGALMDFKTETGAKFYADAADADVLRTGGQSDYEMGKYGATFKPIIPDRTLKNLDKIKLGNTTLTMLHHPGHTKGSCSFVFNTRDGKRKYRVLIANMPSVIVDNKFSEVTAYPNIQSDYAYTFKAMKKLDFDIWVASHASQFDLHEKRKEGAPYNPQLFMDKQSYFQNLNDLEKSYLDKIQKDSQDK	90.00	gnl|BL_ORD_ID|3578|hsp_num:0	4647			480	705	
BGC0000252.1|Nonactin_16 # 15331 # 15558 # 1 # ID=1_16;partial=01;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.684	BGC0000252.1|Nonactin_16 	15331	15558	+	Loose	450	22.7126	RanB	29.31	3005090	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGGCTGAAGTTCTTGTTCTGGTCGATCACGTGGACGGTGCGGTCCGCAAGCCCACCCTGGAGCTGCTGACGCTGGCGCGTCGTGTCGGTGACCCGGTCGCCGTGGTGCTGGGTGCCGGTGCCGGGGACGCTGCCCCGGTGCTGGGTGAGCACGGTGCGGTGAAGGTCCTGACCTCGGACGCCCCGGAGTTCGCGGATTATCTGGTGGTGCCGAAGGTCGACGCGCTG	MAEVLVLVDHVDGAVRKPTLELLTLARRVGDPVAVVLGAGAGDAAPVLGEHGAVKVLTSDAPEFADYLVVPKVDAL	MLKLSKRMLTSVGEYVLLLGKVIKRPQKHNIFFKLLMREINDLGVNSFGLVLFTSIFVGAVVAIQMYNNFKASTIPIPLYFIGYATKVVLILEFSPTIISLILAGKVGSYIASSIGTMRVTEQIDALDIMGVNSPNFLILPKIVANVIFNPLLIAISIVFGIYGGYLAGVATGNWTEADYITGIQRYIPDYFIWYAFFKTVVFAFLIATIPAYFGYNVKGGSLEVGRASTQAVVWTMVAIIIAELISTQLFLS	30.04	gnl|BL_ORD_ID|2807|hsp_num:0	3824			285	435	
BGC0000252.1|Nonactin_10 # 10560 # 11066 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.710	BGC0000252.1|Nonactin_10 	10560	11066	+	Loose	270	24.2534	MexR	27.5	3000506	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACTGACCACGACATCACGCCCGACGCGGGACCCCTCCCGATGCCCGGCTCCGACGGGTTCAGCGACGCGGAAGCCGCCTTCATCAGCGAGATGGGTTCGCTGATGGAGCGCTGGGGCCTCCCGCAGGCCACCGGCCGCCTCTTCGGCTACCTCCTGCTGCGCAACAAGCCGGTGGACCTCGACACCATGACCCGCGAACTCGGCCAGGCCAAGAGCGGGCTGAGTGTGGCCGCCCGCCAACTGGAGGCCTGGTCCCTGGTGCGGCGCTCGACCAGGGCCGGCAGCAGGCGGATCGACTACGAGGCGGTGGGCGACCTCCAGCACCTGCTGCTGGTGAACAACGCCCATATGCGCAAGTTCACCGAGACGCTGAGCTCGGGAATCCCGGTGGCGCGCGGCGAGGCCCGGGACCGACTGGCCTCGCTCGCCGGCCTGTTCAACGGGTACGTGGAGCAGACCGAGGCGCTGGTGGCCGCCTGGGAGGCCCGGCGCGCCGCCACCTGA	MTDHDITPDAGPLPMPGSDGFSDAEAAFISEMGSLMERWGLPQATGRLFGYLLLRNKPVDLDTMTRELGQAKSGLSVAARQLEAWSLVRRSTRAGSRRIDYEAVGDLQHLLLVNNAHMRKFTETLSSGIPVARGEARDRLASLAGLFNGYVEQTEALVAAWEARRAAT	MNYPVNPDLMPALMAVFQHVRTRIQSELDCQRLDLTPPDVHVLKLIDEQRGLNLQDLGRQMCRDKALITRKIRELEGRNLVRRERNPSDQRSFQLFLTDEGLAIHQHAEAIMSRVHDELFAPLTPVEQATLVHLLDQCLAAQPLEDI	114.29	gnl|BL_ORD_ID|2333|hsp_num:0	1474			153	273	erythromycin; ciprofloxacin; tetracycline; ceftazidime; ceftriaxone; meropenem; novobiocin; azithromycin; trimethoprim; sulfamethoxazole; chloramphenicol; aztreonam; colistin A; colistin B; ampicillin; panipenem; trimethoprim-sulfamethoxazole
